BioRestorative enters ATM equity facility with JonesTrading for up to $3.7M

BioRestorative Therapies, Inc.

Capital On Demand Sales Agreement signed April 14, 2023 with JonesTrading Institutional Services LLC.
Company may sell up to $3.7 million of common stock from time to time in at-the-market offerings.
Agent commission is 3.0% of gross sale proceeds; company not obligated to sell any shares.
Sales will be under existing effective S-3 registration statement (No. 333-269631) filed Feb 2023.
Agreement can be terminated by either party at any time upon notice.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

BioRestorative Therapies, Inc. entered into Sales Agreement with JonesTrading Institutional Services LLC valued at up to $3.7 million (effective 2023-04-14).

Action: entry
Agreement: atm program
Counterparty: JonesTrading Institutional Services LLC
Value: up to $3.7 million
Effective: 2023-04-14

Exact text from the filing

BioRestorative Therapies, Inc. (the “Company”) entered into a Capital On DemandTM Sales Agreement (the “Sales Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through or to the Agent, shares of the Company’s common stock, par value $0.0001 per share, having an aggregate offering price of up to $3.7 million

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

BioRestorative Therapies, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-012377

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.